Navigation Links
AEterna Zentaris Reports First Quarter 2009 Financial and Operating Results
Date:5/6/2009

March 31, 2009, compared to the same period in 2008. The increase is also related to a gain recorded in the three-month period ended March 31, 2008 on the disposal of Impavido(R), partially offset by the reduction in loss from operations in the three-month period ended March 31, 2009.

Consolidated cash, cash equivalents and short-term investments were $62.5 million as at March 31, 2009.

CONFERENCE CALL

Management will be hosting a conference call for the investment community beginning at 3:30 p.m. Eastern Time today, Wednesday, May 6, 2009, to discuss first quarter 2009 results. Individuals interested in participating in the live conference call by telephone may dial 416-644-3422, 514-807-8791 or 800-587-1893, or may listen through the Internet at www.aezsinc.com. A replay will be available on the Company's website for 30 days following the live event.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aezsinc.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutica
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. AEterna Zentaris to Announce Third Quarter 2007 Financial and Operating Results on November 7, 2007
2. AEterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Minneapolis, MN (PRWEB) June 03, 2015 ... new wellness "events" programming module. With this highly ... up, run and report on many components of its ... service at no additional charge. , With this new ... (1) Integrate DE challenges, (2) Create participant surveys, (3) ...
(Date:6/3/2015)... “ Scanalytics ” was featured on NewsWatch as part ... and coolest technology products available to consumers. Andrew Tropeano, ... the review and shared with viewers how this technology ... , Tracking statistics in business is invaluable in analyzing ... this goes a step beyond revenue statistics and tracking ...
(Date:6/3/2015)... Fit Body Boot Camp is ... The company helps thousands of individuals across the country lose ... to hit the gym and get the fitness results they ... the most out any gym membership: , Tip #1 – ... gym memberships is saying motivated and on track. Attempting to ...
(Date:6/3/2015)... Come on out in support of the ... relay beginning in Madison, Wisconsin on Friday, June 12th ... , For the 4th consecutive year, a very dedicated ... raise money for the Brain Aneurysm Foundation. , The ... Neurosurgery staff from The University of Illinois Medical Center, ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Unfortunately, a majority ... it comes to providing comfort to the users throughout the ... brand or one from the local market, the makers generally ... and, in the process, often overlook comfort and health. To ... of shoe, the creative heads at Vay Technologies have come ...
Breaking Medicine News(10 mins):Health News:DailyEndorphin Launches Wellness "Events" Portal 2Health News:Technology to Analyze Foot Traffic in Retail Stores was featured on NewsWatch Television 2Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 2Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 3Health News:4th Annual Ragnar Relay from Madison, WI to Chicago, IL Once Again Benefits Renowned Brain Aneurysm Foundation 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 3
... WEDNESDAY, Dec. 7 (HealthDay News) -- Women with breast cancer ... risk of a mastectomy later on, compared with women who ... This type of targeted radiation, known as brachytherapy, also ... study. "We were very surprised by the results," said ...
... have compared internet use and frequency in Spain with the ... Spanish women use the internet less frequently and the usage ... average. Juan Martn Fernandez, researcher at the Complutense University ... in the Reis journal, states that "Spanish men ...
... (DH), the process of electronically recording and numerically ... in recent years. To highlight breakthroughs in this ... ( http://www.osa.org )) journal Applied Optics ... of the journal Chinese Optics Letters ...
... sewage treatment plants may contain significant concentrations of the ... a new study on a sewage treatment plant on ... in ACS, journal Environmental Science & Technology. ... bacteria a major problem in medicine today ...
... Steven Reinberg HealthDay Reporter , WEDNESDAY, Dec. 7 ... panels will meet Thursday to discuss whether to recommend new ... forms of oral contraceptives. The Reproductive Health Drugs ... Committee will hear from experts and the public, and then ...
... approach to treating breast cancer, Loyola University Medical Center researchers ... drug that targets tumor stem cells., Existing cancer drugs are ... cancer stem cells are resistant to such drugs. They survive ... pilot study at Loyola found that an experimental drug known ...
Cached Medicine News:Health News:Targeted Radiation May Not Be Better for Breast Cancer 2Health News:Targeted Radiation May Not Be Better for Breast Cancer 3Health News:Spain's digital gender gap is larger than European average 2Health News:Applied Optics focus issue: Digital holography and 3-D imaging 2Health News:Applied Optics focus issue: Digital holography and 3-D imaging 3Health News:Applied Optics focus issue: Digital holography and 3-D imaging 4Health News:FDA Panels to Weigh Safety of Newer Forms of the 'Pill' 2Health News:FDA Panels to Weigh Safety of Newer Forms of the 'Pill' 3Health News:Novel approach to treating breast cancer shows great promise 2
(Date:6/3/2015)... 2015   Health Data Consortium (HDC) , a public-private partnership whose ... data to improve health and healthcare, today announced ... the Office of Enterprise Data and Analytics at the ... recipient of this year,s Health Data Liberators Award ... innovative ways to help improve the quality and value ...
(Date:6/3/2015)... MINNEAPOLIS , June 3, 2015 Creekridge ... growth of its sales channels by adding two new ... company as a Regional Sales Manager and Stefanie ... Mr. Puma comes to Creekridge with over ... In his role at Creekridge, Mr. Puma will be ...
(Date:6/3/2015)... , June 3, 2015 ... "Interventional Cardiology & Peripheral Vascular Devices Market (Embolic ... Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons ... MarketsandMarkets, the Interventional Cardiology and Peripheral Vascular Devices ... by 2019 with a CAGR of 7.4% from ...
Breaking Medicine Technology:CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 2CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 3CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 4Creekridge Capital Strengthens Sales Team 2The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 2The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 3The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 4
... Calif., March 10 Bionovo, Inc.,(Nasdaq: BNVI ... which showed MF101 could become first-line treatment for ... quantitative,studies, 124 physicians board certified in internal medicine ... menopause reported MF101,if approved, would be their drug ...
... March 7 The,Journal of the American College of ... (Deferral Versus Performance of PTCA in,Patients Without Documented Ischemia) ... on cardiology in 2007, according to an article entitled,"Highlights ... MD, et al. (JACC,Vol. 51, No. 4, 2008 January ...
Cached Medicine Technology:Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms 2Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms 3JACC Identifies DEFER with 5-year Outcomes as Landmark Trial 2
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
... products are offered as 1-piece or modular, ... modular instruments may be customized with handles ... ratchets, insulation and flush ports. Many standard ... specifications may affect delivery times. , ...
... a layered design unique in the industry. ... prevent stray electrosurgical burns along the shaft ... or capacitive coupling; a well-documented patient safety ... AEM Instruments provides a neutral return path ...
Medicine Products: